BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16266744)

  • 21. Comparison of biological behavior between early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
    Fregnani JH; Soares FA; Novik PR; Lopes A; Latorre MR
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):215-23. PubMed ID: 17125903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: cytomorphologic observation of five cases.
    Khunamornpong S; Siriaunkgul S; Suprasert P
    Diagn Cytopathol; 2002 Jan; 26(1):10-4. PubMed ID: 11782079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors influencing decisions about surgical treatment of villoglandular adenocarcinoma of the uterine cervix.
    Kim HJ; Sung JH; Lee E; Ahn S; Song SY; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
    Int J Gynecol Cancer; 2014 Sep; 24(7):1299-305. PubMed ID: 24987921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Villoglandular papillary adenocarcinoma of the cervix. Beware of a wolf in sheep's clothing.
    Bouman A; Oosterhuis GJ; Naudin ten Cate L; van Doorn GA
    Eur J Obstet Gynecol Reprod Biol; 1999 Dec; 87(2):183-9. PubMed ID: 10597972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Minimally deviated adenocarcinoma (malignant adenoma) of the cervix uteri].
    Gutiérrez Vega PA; Palones JM; Xercavins J; García A
    Ginecol Obstet Mex; 2001 Feb; 69():82-7. PubMed ID: 11339179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A case of highly differentiated adenocarcinoma of the uterine cervix. (Malignant adenoma of Anglo-Saxon authors)].
    Hebert H; Hezarkhani M; Abelanet R; Auriol M; Fradet-Gentile A; Gest J; Guerin P
    Sem Hop; 1972 Apr; 48(20):1425-33. PubMed ID: 4340952
    [No Abstract]   [Full Text] [Related]  

  • 27. Villoglandular adenocarcinoma of the uterine cervix-a systematic review of the literature.
    Heatley MK
    Histopathology; 2007 Aug; 51(2):268-9. PubMed ID: 17593209
    [No Abstract]   [Full Text] [Related]  

  • 28. Mesonephric adenocarcinoma of the cervix: a case report and review of the literature.
    Yap OW; Hendrickson MR; Teng NN; Kapp DS
    Gynecol Oncol; 2006 Dec; 103(3):1155-8. PubMed ID: 17023031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intranuclear cytoplasmic inclusion is a significant diagnostic feature for the differentiation of lobular endocervical glandular hyperplasia from minimal deviation adenocarcinoma of the cervix.
    Hashi A; Yuminamochi T; Xu JY; Kondo T; Katoh R; Hoshi K
    Diagn Cytopathol; 2008 Aug; 36(8):535-44. PubMed ID: 18618730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microinvasive cervical adenocarcinoma (FIGO stage 1A tumors): results of surgical staging and outcome analysis.
    Ceballos KM; Shaw D; Daya D
    Am J Surg Pathol; 2006 Mar; 30(3):370-4. PubMed ID: 16538058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Term delivery following conservative treatment for villoglandular papillary adenocarcinoma of the uterine cervix: report of a case and analysis of the literature.
    Hoffman JS; Bazzurini L; Laird L; Murphy JC; Magriples U; Lewis J
    Gynecol Oncol; 2001 May; 81(2):310-3. PubMed ID: 11330967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic adenocarcinoma in the uterine cervix. A report of two autopsy cases.
    Ihara T; Shinno A; Yamashita M; Hiura M; Inada S
    Acta Obstet Gynaecol Jpn; 1974 Jan; 21(1):9-14. PubMed ID: 4469124
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical features and prognostic factors of cervical villoglandular adenocarcinoma.
    Chen JH; Duan H; Yu XB; Zhao HW; Chen X; Li P; Li ZQ; Li BX; Pan LY; Yan X; Chen C
    Int J Gynecol Cancer; 2021 Apr; 31(4):512-517. PubMed ID: 33608452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A falsely reassuring cervical smear in adenocarcinoma of the external os].
    Rooker D; Baalbergen A; Helmerhorst TJ
    Ned Tijdschr Geneeskd; 2008 Apr; 152(17):977-80. PubMed ID: 18549169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationship between histological pattern and prognosis of squamoadenocarcinoma of the cervix (author's transl)].
    Tang SE
    Zhonghua Fu Chan Ke Za Zhi; 1981 Jan; 16(1):45-7. PubMed ID: 7297236
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of microinvasive adenocarcinoma of the uterine cervix: a retrospective study and review of the literature.
    Bisseling KC; Bekkers RL; Rome RM; Quinn MA
    Gynecol Oncol; 2007 Dec; 107(3):424-30. PubMed ID: 17707895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome.
    Guo P; Liu P; Yang J; Ren T; Xiang Y
    Cancer Manag Res; 2018; 10():3955-3961. PubMed ID: 30310316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Villoglandular papillary adenocarcinoma of the uterine cervix: a case report and literature review.
    González-Bosquet E; Suñol M; Morante D; Gomez Latre M; Callejo J; Lailla JM
    Eur J Gynaecol Oncol; 2009; 30(2):211-3. PubMed ID: 19480259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mullerian adenosarcoma of uterine cervix: report of three cases and review of literature.
    Manoharan M; Azmi MA; Soosay G; Mould T; Weekes AR
    Gynecol Oncol; 2007 Apr; 105(1):256-60. PubMed ID: 17292949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Retrospective Study and Literature Review of Cervical Villoglandular Adenocarcinoma: A Candidate Paradigm of Silva System Pattern A.
    Zhang Y; Wang Y; Liu Y; Yang J; Liu C
    Appl Immunohistochem Mol Morphol; 2021 Jul; 29(6):467-472. PubMed ID: 33337634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.